Compare OGN & LC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OGN | LC |
|---|---|---|
| Founded | 1923 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.0B |
| IPO Year | N/A | 2014 |
| Metric | OGN | LC |
|---|---|---|
| Price | $7.88 | $17.24 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 5 | 6 |
| Target Price | $14.10 | ★ $22.67 |
| AVG Volume (30 Days) | ★ 6.2M | 2.8M |
| Earning Date | 02-12-2026 | 01-28-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | N/A | ★ 157.78 |
| EPS | ★ 1.91 | 1.16 |
| Revenue | ★ $6,301,000,000.00 | $1,334,719,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $16.15 |
| P/E Ratio | ★ $4.14 | $14.91 |
| Revenue Growth | N/A | ★ 14.97 |
| 52 Week Low | $6.18 | $7.90 |
| 52 Week High | $17.23 | $21.67 |
| Indicator | OGN | LC |
|---|---|---|
| Relative Strength Index (RSI) | 41.94 | 42.19 |
| Support Level | $7.74 | $15.24 |
| Resistance Level | $8.48 | $17.72 |
| Average True Range (ATR) | 0.42 | 0.96 |
| MACD | -0.17 | -0.24 |
| Stochastic Oscillator | 6.59 | 31.03 |
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.
LendingClub Corp is a company engaged in operating an online lending marketplace platform that connects borrowers and investors for the provision of the loan facility. It offers investors access to an asset class that has generally been closed to many investors and only available on a limited basis to institutional investors. The company through the platform offers loan products such as personal, education and patient finance, small business, and auto to interested investors. It generates a majority of the revenue from the transaction fees received from the platform's role in accepting and decisioning applications on behalf of the bank partners to enable loan originations.